These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24319232)

  • 1. Dissecting follicular lymphoma: high versus low risk.
    Smith SM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of follicular lymphomas.
    Luminari S; Federico M
    Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
    Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C
    Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
    Boughan KM; Caimi PF
    Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model.
    Andjelić B; Todorović-Balint M; Antić D; Bila J; Djurašinović V; Mihaljević B
    Vojnosanit Pregl; 2015 Jan; 72(1):26-32. PubMed ID: 26043587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.
    Gangatharan SA; Maganti M; Kuruvilla JG; Kukreti V; Tiedemann RE; Gospodarowicz MK; Hodgson DC; Sun A; Tsang RW; Pintilie M; Crump M
    Br J Haematol; 2015 Aug; 170(3):384-90. PubMed ID: 25904266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of prognostic indices in patients with follicular lymphomas.
    Radojkovic M; Ristic S; Colovic M; Mihaljevic B; Cemerikic-Martinovic V
    Med Oncol; 2006; 23(4):533-42. PubMed ID: 17303912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
    Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
    Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic tools in follicular lymphomas.
    Luminari S; Cox MC; Montanini A; Federico M
    Expert Rev Hematol; 2009 Oct; 2(5):549-62. PubMed ID: 21083020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma: are we ready for a risk-adapted approach?
    Kahl BS
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):358-364. PubMed ID: 29222279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel acquisitions on biology and management of transformed follicular lymphoma.
    Minoia C; Zucca E; Conconi A
    Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
    Matasar MJ; Luminari S; Barr PM; Barta SK; Danilov AV; Hill BT; Phillips TJ; Jerkeman M; Magagnoli M; Nastoupil LJ; Persky DO; Okosun J
    Oncologist; 2019 Nov; 24(11):e1236-e1250. PubMed ID: 31346132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.